Lumacaftor/Ivacaftor Treatment of Patients with Cystic Fibrosis Heterozygous for F508del-CFTR

Rowe, S. M.; McColley, S. A.; Rietschel, E.; Li, X.; Bell, S. C.; Konstan, M. W.; Marigowda, G.; Waltz, D.; Boyle, M. P.

Ann Am Thorac Soc. 2016 Nov 30; 14(2):213-219

Abstract

RATIONALE: In a prior study, lumacaftor/ivacaftor treatment (

Read More on PubMed